Physician profile
Pier Pasquale Leone
NPI 1609576735
$43,293.01
in general payments reported to CMS, 2019-2025
19 companies · $6,232 in 2025
The $6,232 reported for 2025 was more than what 85% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $2,053 · 2024: $35K · 2025: $6,232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $30K · Food and Beverage: $11K · Travel and Lodging: $2,078 · Education: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $30,000.00 |
| Food and Beverage | $11,030.21 |
| Travel and Lodging | $2,078.39 |
| Education | $184.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $32,901.33 | 2024-2025 | Corevalve Evolut R, Symplicity G3, Ffrangio |
| Edwards Lifesciences Corporation | $3,714.70 | 2023-2025 | Pascal, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Evoque |
| W. L. Gore & Associates, INC. | $2,296.48 | 2023-2025 | Gore Cardioform Septal Occluder, Gore Cardioform Asd Occluder, Gore Viabahn Vbx Balloon Expandable Endo |
| Shockwave Medical, INC | $1,097.85 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $1,072.21 | 2023-2025 | Impella |
| Terumo Medical Corporation | $726.04 | 2023-2024 | Glidesheath Slender, Azur Cx Detachable, Metacross Otw |
| Boston Scientific Corporation | $416.49 | 2023-2024 | Avvigo Guidance System, Mach1, Polaris Ultra |
| Chiesi USA, INC. | $244.84 | 2023-2024 | Kengreal, Cleviprex |
| Cardiva Medical, INC. | $186.75 | 2023-2024 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 5f Vcs, Optowire |
| Bard Peripheral Vascular, INC. | $178.15 | 2023-2024 | Lutonix Drug Coated Balloon, Ultraverse 014, Halo One Thin-Walled Guiding Sheath |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $115.31 | 2023-2024 | Lifevest |
| Janssen Pharmaceuticals, INC | $89.91 | 2023-2024 | Xarelto |
| Teleflex LLC | $56.05 | 2023 | Manta, Langston |
| Novartis Pharmaceuticals Corporation | $46.76 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $39.08 | 2023-2024 | Farxiga, Andexxa |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Asahi Intecc USA, INC. | $33.27 | 2023 | Asahi Ptca Guide Wire |
| Cook Medical LLC | $31.93 | 2024 | Zilver Ptx |
| Biotronik INC. | $27.46 | 2024 | Orsiro Mission |
| Abbott Laboratories | $18.40 | 2025 | Mitraclip |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pier Pasquale Leone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.